Onno van Hooij Selected Research

human CBX5 protein

1/2022

Delivery of antisense oligonucleotides for splice-correction of androgen receptor pre-mRNA in castration-resistant prostate cancer models using cell-penetrating peptides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Onno van Hooij Research Topics

Disease

5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2007
5	Neoplasms (Cancer) 02/2021 - 02/2009
1	Lung Neoplasms (Lung Cancer) 02/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2009

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	Cadherins (E-Cadherin)IBA 02/2021 - 01/2017
1	human CBX5 proteinIBA 01/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	RNA Precursors (Precursor, mRNA)IBA 01/2022
1	Antisense OligonucleotidesIBA 01/2022
1	Cell-Penetrating PeptidesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2021
1	Abiraterone AcetateIBA 01/2021
1	enzalutamideIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2017
1	ORALIT (ORS)IBA 02/2009
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2007
1	AntigensIBA 02/2007

Therapy/Procedure

4	Castration 01/2022 - 01/2020
2	Therapeutics 01/2022 - 01/2021
1	Prostatectomy (Retropubic Prostatectomy) 01/2010